Medical Devices
Technology
Health

Cantel Medical

$68.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.18 (-0.26%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Cantel Medical and other stocks, options, ETFs, and crypto commission-free!

About

Cantel Medical Corp. engages in the development and manufacture of infection prevention products and services in the healthcare market. It operates through the following business segments: Endoscopy; Water Purification and Filtration; Healthcare Disposables; and Dialysis. Read More The Endoscopy segment includes endoscope reprocessing and endoscopy procedure products. The Water Purification and Filtration segment provides filtration and disinfectant technologies to the medical and life science markets through a distributor network. The Healthcare Disposables segment designs, manufactures, sells, supplies, and distributes infection prevention healthcare products, the majority of which are single-use products used by dental practitioners. The Dialysis segment develops and markets service reprocessing systems and sterilants for dialyzers, as well as dialysate concentrates and supplies utilized for renal dialysis. The company was founded on August 16, 1963 and is headquartered in Little Falls, NJ.

Employees
2,693
Headquarters
Little Falls, New Jersey
Founded
1963
Market Cap
2.88B
Price-Earnings Ratio
38.98
Dividend Yield
0.18
Average Volume
292.76K
High Today
$68.89
Low Today
$67.72
Open Price
$68.42
Volume
158.27K
52 Week High
$130.92
52 Week Low
$63.47

Collections

Medical Devices
Technology
Health
Medical
Healthcare
US
North America

News

Yahoo Finance17h

Analysts Estimate Cantel Medical to Report a Decline in Earnings: What to Look Out for

Wall Street expects a year-over-year decline in earnings on higher revenues when Cantel Medical (CMD) reports results for the quarter ended April 2019. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

3
Seeking AlphaMay 13

New finance and operating chief at Cantel

Cantel Medical (NYSE:CMD) has promoted Peter Clifford has been promoted to Executive Vice President and Chief Operating Officer. Shaun Blakeman has been appointed as Senior Vice President and Chief Financial Officer. Mr. Clifford and Mr. Blakeman will serve on the Executive Leadership Team. Most recently, Mr. Clifford served as Vice President of Operations, Finance and Information Technology of IDEX Corporation, and held various senior financial positions for General Electric. Most recently, Shaun was Se...

11
TradingNewsNowMay 7

Stock Valuation: Cantel Medical Corp. (NYSE: CMD)

Cantel Medical Corp. trades as part of the healthcare sector and trades as part of the medical instruments and equipment industry. The company CEO is George L. Fotiades. Cantel Medical Corp is dedicated in delivering infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Previous Intraday Trading Performance: The CMD stock showed a previous change of 1.81% with an open at 67.77 and a close of 70.17. It...

5

Earnings

$0.54
$0.57
$0.59
$0.62
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
$0.56 per share
Actual
Expected Jun 4, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.